Abstract:Cumulative evidence has established that Interferon (IFN)-γ has both pathogenic and protective roles in Multiple Sclerosis and the animal model, Experimental Autoimmune Encephalomyelitis (EAE). However, the underlying mechanisms to the beneficial effects of IFN-γ are not well understood. In this study, we found that IFN-γ exerts therapeutic effects on chronic, relapsing-remitting, and chronic progressive EAE models. The frequency of regulatory T (Treg) cells in spinal cords from chronic EAE mice treated with IFN-γ was significantly increased with no effect on Th1 and Th17 cells. Consistently, depletion of FOXP3-expressing cells blocked the protective effects of IFN-γ, indicating that the therapeutic effect of IFN-γ depends on the presence of Treg cells. However, IFN-γ did not trigger direct in vitro differentiation of Treg cells. In vivo administration of blocking antibodies against either interleukin (IL)-10, transforming growth factor (TGF)-β or program death (PD)-1, revealed that the protective effects of IFN-γ in EAE were also dependent on TGF-β and PD-1, but not on IL-10, suggesting that IFN-γ might have an indirect role on Treg cells acting through antigen-presenting cells. Indeed, IFN-γ treatment increased the frequency of a subset of splenic CD11b + myeloid cells expressing TGF-β-Latency Associated Peptide (LAP) and program death ligand 1 (PD-L1) in a signal transducer and activator of transcription (STAT)-1-dependent manner. Furthermore, splenic CD11b + cells from EAE mice preconditioned in vitro with IFN-γ and myelin oligodendrocyte glycoprotein (MOG) peptide exhibited a tolerogenic phenotype with the capability to induce conversion of naïve CD4 + T cells mediated by secretion of TGF-β. Remarkably, adoptive transfer of splenic CD11b + cells from IFN-γ-treated EAE mice into untreated recipient mice ameliorated clinical symptoms of EAE and limited central nervous system infiltration of mononuclear cells and effector helper T cells. These results reveal a novel cellular and molecular mechanism whereby IFN-γ promotes beneficial effects in EAE by endowing splenic CD11b + myeloid cells with tolerogenic and therapeutic activities.

Cutting Edge: Ifn-Gamma Enables Apc To Promote Memory Th17 And Abate Th1 Cell Development

Cutting edge: IFN-γ enables APC to promote memory Th17 and Abate Th1 cell development

Role of Ifn-Gamma in Induction of Foxp3 and Conversion of Cd4(+)Cd25(-) T Cells to Cd4(+) Tregs

Cutting Edge: IL-12 and IL-18 Differentially Regulate the Transcriptional Activity of the Human IFN-γ Promoter in Primary CD4+ T Lymphocytes

IFN-γ Differentially Regulates Subsets of Gr-1(+)CD11b(+) Myeloid Cells in Chronic Inflammation.

Nk-Dc Crosstalk Controls The Autopathogenic Th17 Response Through An Innate Ifn-Gamma-Il-27 Axis

TNFalpha and TGF-beta1 influence IL-18-induced IFNgamma production through regulation of IL-18 receptor and T-bet expression.

Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells.

Ifn-Gamma Suppresses Il-10 Production and Synergizes with Tlr2 by Regulating Gsk3 and Creb/Ap-1 Proteins

IFN-β Regulates Th17 Differentiation Partly Through the Inhibition of Osteopontin in Experimental Autoimmune Encephalomyelitis.

Interferonγ and IL-27 positively regulate type 1 regulatory T-cell development during adaptive tolerance

Cutting Edge: Th17 and Regulatory T Cell Dynamics and the Regulation by IL-2 in the Tumor Microenvironment.

Type I interferon inhibits acute IL-5 and IL-13 expression in human memory CD4+ T cells (125.12)

Role of IFN-γ and IL-12 in Silencing the IL-4-Producing Potential in Th1 Cells (87.29)

IFN-γ Signaling in Astrocytes and Microglia Has Opposite Roles in CNS Autoimmunity (P5170)

Regulation of IFN-gamma production by B effector 1 cells: essential roles for T-bet and the IFN-gamma receptor

IFN-γ suppresses permissive chromatin remodeling in the regulatory region of the Il4 gene.

IFNgamma Induces Expansion of Hematopoietic Progenitor Cells (36.9)

Therapeutic role of interferon-γ in experimental autoimmune encephalomyelitis is mediated through a tolerogenic subset of splenic CD11b+ myeloid cells

Brief Report: Interferon-Gamma Induces Expansion of Lin(-)Sca-1(+)C-Kit(+) Cells

Independent and Interdependent Immunoregulatory Effects of IL-27, IFN-β, and IL-10 in the Suppression of Human Th17 Cells and Murine Experimental Autoimmune Encephalomyelitis.